Myriad Genetics (MYGN) Insider Trading & Ownership $5.33 -0.01 (-0.21%) As of 11:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Myriad Genetics (NASDAQ:MYGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.90M Get MYGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Myriad Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MYGN Insider Buying and Selling by Quarter Myriad Genetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/11/2024Paul J DiazCEOSell15,000$22.93$343,950.00 9/9/2024Heinrich DreismannDirectorSell10,000$27.05$270,500.00 9/3/2024Colleen F ReitanDirectorSell46,012$27.95$1,286,035.40 (Data available from 1/1/2013 forward) MYGN Insider Trading Activity - Frequently Asked Questions Who is on Myriad Genetics' Insider Roster? The list of insiders at Myriad Genetics includes Colleen F Reitan, Daniel K Spiegelman, Heinrich Dreismann, Lee Nisley Newcomer, Nicole Lambert, Paul J Diaz, and Richard Bryan Riggsbee. Learn more on insiders at MYGN. What percentage of Myriad Genetics stock is owned by insiders? 2.40% of Myriad Genetics stock is owned by insiders. Learn more on MYGN's insider holdings. Which Myriad Genetics insiders have been selling company stock? The following insiders have sold MYGN shares in the last 24 months: Colleen F Reitan ($1,286,035.40), Daniel K Spiegelman ($83,487.52), Heinrich Dreismann ($270,500.00), Lee Nisley Newcomer ($156,860.00), Paul J Diaz ($3,677,819.72), and Richard Bryan Riggsbee ($470,700.00). How much insider selling is happening at Myriad Genetics? Insiders have sold a total of 243,844 Myriad Genetics shares in the last 24 months for a total of $5,945,402.64 sold. Myriad Genetics Key ExecutivesMr. Paul J. Diaz (Age 62)CEO, President & Director Compensation: $2.31MMr. Samraat S. Raha (Age 51)Chief Operating Officer Compensation: $514.76kDr. Dale Muzzey Ph.D. (Age 44)Chief Scientific Officer Compensation: $816.5kMr. Mark S. Verratti (Age 56)Chief Commercial Officer Compensation: $915.81kMr. Scott J. Leffler (Age 49)Chief Financial Officer Ms. Natalie Munk (Age 43)Principal Accounting Officer Dr. Kevin Richard Haas Ph.D. (Age 38)Chief Technology Officer Compensation: $580.36kMr. Matthew ScaloSenior Vice President of Investor RelationsMr. Glenn FarrellSenior VP & Chief Marketing OfficerMs. Shereen Solaiman (Age 51)Chief People Officer More Insider Trading Tools from MarketBeat Related Companies FOLD Insider Trades BCRX Insider Trades CLDX Insider Trades DVAX Insider Trades INVA Insider Trades MNKD Insider Trades NVAX Insider Trades OPK Insider Trades GERN Insider Trades RGLS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity This page (NASDAQ:MYGN) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
